Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Enanta Pharmaceuticals (ENTA) Return on Capital Employed (2016 - 2025)

Enanta Pharmaceuticals (ENTA) has disclosed Return on Capital Employed for 13 consecutive years, with 0.28% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Return on Capital Employed rose 7.0% year-over-year to 0.28%, compared with a TTM value of 0.28% through Dec 2025, up 7.0%, and an annual FY2025 reading of 0.3%, up 3.0% over the prior year.
  • Return on Capital Employed was 0.28% for Q4 2025 at Enanta Pharmaceuticals, up from 0.35% in the prior quarter.
  • Across five years, Return on Capital Employed topped out at 0.19% in Q1 2021 and bottomed at 0.42% in Q1 2023.
  • Average Return on Capital Employed over 5 years is 0.34%, with a median of 0.35% recorded in 2025.
  • The sharpest move saw Return on Capital Employed dropped -21bps in 2021, then rose 7bps in 2025.
  • Year by year, Return on Capital Employed stood at 0.32% in 2021, then decreased by -15bps to 0.36% in 2022, then decreased by -2bps to 0.37% in 2023, then grew by 5bps to 0.35% in 2024, then rose by 20bps to 0.28% in 2025.
  • Business Quant data shows Return on Capital Employed for ENTA at 0.28% in Q4 2025, 0.35% in Q3 2025, and 0.36% in Q2 2025.